Medische hulpmiddelen en geneesmiddelen: Verschuivende grenzen in Brussel?
|
|
- Francine Short
- 8 years ago
- Views:
Transcription
1 Medische hulpmiddelen en geneesmiddelen: Verschuivende grenzen in Brussel? Sabina Hoekstra-van den Bosch Philips HealthTech, Global Regulations & Standards Arnhem, June 19, 2015
2 Samenvatting Verschil tussen geneesmiddel en medisch hulpmiddel (herhaling) Nieuw mechanisme voor statusbepaling van medische hulpmiddelen op Europees niveau Substance based medical devices 2 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
3 Fundamental difference between medical device and pharmaceutical 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
4 Simplified EU definition of a medical device Any product Intended for a medical purpose For humans Which does not act by pharmacological, immunological or metabolic means Fundamental difference with pharmaceutical products is mechanism of action 5 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
5 Statusbepaling van medische hulpmiddelen op Europees niveau 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
6 Statusbepaling medische hulpmiddelen in EU Huidige situatie Majority of cases: no doubt! In case of doubt: No seamless coherence between the definitions of medicinal products and medical device Decisive power lies with national judges Possibility to appeal to EU Court of Justice Demarcation procedure between pharmaceuticals and medical devices can be quite complicated! 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
7 Nieuw mechanisme voor statusbepaling? EU COM proposal MDR + Council changes 3 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
8 Wat betekent dit??? Sleutelwoorden/begrippen Art 2.2 of Directive 2001/83 Implementing acts MDCG 5 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
9 Medicinal Product Directive 2001/83, art 2.2 In cases of doubt, where, taking into account all its characteristics, a product may fall within the definition of a medicinal product and within the definition of a product covered by other Community legislation the provisions of this Directive shall apply. 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
10 Comitology Legislative process light System gradually developed from the 60-ties For implementing measures only Drafted by EU COM Voted upon by Council (Member States) by QMV European Parliament asked for the equal rights as co-legislator 2006: Veto right for European Parliament 10 1
11 Treaty of Lisbon (2010) Fundamental changes to comitology procedures, now called implementing acts Creation of a new legal instrument for delegation to EU Commission: delegated acts. Equality between EP and Council in limited control over both delegated and implementing acts (veto-right) And the winner is
12 Medical Device Coordination Group (MDCG) Commission proposal MDR art 80 Consisting of representatives of Member States (1 for MDs, 1 for IVDs, with an alternate for each) Members chosen for their competence and experience Members must be impartial Chaired and supported (logistically, technically and scientifically) by EU Commission Experts of other stakeholders (medical device industry, healthcare professionals, laboratories, patients and consumers) may be invited in subgroups as observer on case-by-case basis 12 1
13 Wat betekent dit als Medical Device Regulation van kracht is? Regulation (=Verordening) rechtstreeks van toepassing in alle lidstaten Statusbepaling dmv Implementing acts met Europese Commissie aan het roer MDCG (lidstaten) worden tevoren geraadpleegd Beroep tegen Implementing act ingewikkeld (voor gevorderde Europees juristen.) 5 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
14 substance based medical devices 13 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
15 substance based medical devices Background Increasing number of ingested or absorbed products with medical claims Not possible to demonstrate that (some of) these products have any pharmacological, immunological or metabolic action/effect Historically a lot of these products have been placed on the market as medicinal products Identical products regulated as medicinal products, medical devices or food supplements. Differences in interpretation between Member States, but also within Member States. When the Medical Device Directive was drafted (mid-eighties), legislators did not intend to cover products which are ingested or absorbed, so some adaptation might be needed in order to cover these products properly. Examples: some nasal sprays, gels for vaginal discomfort, throat lozenges, toothpastes for sensitive teeth, flushing solutions, creams to treat or prevent minor skin irritations, comfort eye drops or anti-flatulence products 15 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
16 substance based medical devices Solution: substance based medical devices defined in MDR: Adaptation of Classification rules General Safety and Performance Requirements Conformity Assessment Procedures Labelling and Instructions for use Referral to relevant provisions in 2001/83 Provoked lots of intense discussion, e.g. on Definition Risk classification 15 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
17 Definition of substance based medical devices EU COM proposal MDR + Council changes Devices that are composed of substances or combinations of substances that are intended to be ingested inhaled or administered rectally or vaginally introduced into the human body via a body orifice, or applied on skin and that are absorbed by or locally dispersed in the human body 16 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
18 Classification of substance based medical devices (Annex VII) 19 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
19 General Safety and Performance Requirements MDR Annex I 14 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
20 Labelling MDR Annex I, Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
21 Instructions for use MDR Annex I, Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
22 Technical documentation Annex II Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
23 Dank voor uw aandacht! 24 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards
24
Implementing & Delegated Acts
Implementing & Delegated Acts Some Principles jos.dumortier@timelex.eu 1 Executive Acts: why? filling in the gaps or dealing with details jos.dumortier@timelex.eu 2 Legislative Process Commission PROPOSES
More informationThe information contained in these slides is for general purposes only and presents the state of knowledge at November 30, 2011
1 The information contained in these slides is for general purposes only and presents the state of knowledge at November 30, 2011 No rights can be derived from this information The Medicines Evaluation
More informationCE Marking Changing & Evolving Requirements September 2013 2013 BSI Healthcare Roadshow
CE Marking Changing & Evolving Requirements September 2013 2013 BSI Healthcare Roadshow Existing Directives 2 Directive 93/42/EEC 1. Check Scope of Medical Device Directive (Article 1) 2. Determine Device
More informationUpdate: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR)
Update: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR) Paul Brooks Healthcare Solutions Disclaimer The new regulations are not finalized and subject to change http://medicaldevices.bsigroup.com/en-us/resources/whitepapers-and-articles/
More informationDraft conclusions of the Council and of the Member States on the civil and commercial justice systems of the Member States
COUNCIL OF THE EUROPEAN UNION Brussels, 20 February 2014 6771/14 FREMP 29 JAI 103 JUSTCIV 44 NOTE from: to: Subject: Coreper Council Draft conclusions of the Council and of the Member States on the civil
More informationInformatiebeveiliging volgens ISO/IEC 27001:2013
Informatiebeveiliging volgens ISO/IEC 27001:2013 Dave Hagenaars, directeur BSI Group Nederland Copyright 2012 BSI. All rights reserved. Inhoud Wie zijn wij? Waarom informatiebeveiliging? Wat is de relevantie
More informationTRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP
DISCLAIMER: The EU reserves the right to make subsequent modifications to this text and to complement its proposals at a later stage, by modifying, supplementing or withdrawing all, or any part, at any
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health products and systems Medicinal products quality, safety and efficacy Brussels, 15 May 2013 sanco.ddg1.d.6(2013)1154216 THE RULES GOVERNING
More informationBrief Summary on the Philippine B bilateral Air Services Agreement
EUROPEAN COMMISSION Brussels, 27.5.2016 COM(2016) 303 final 2016/0156 (NLE) Proposal for a COUNCIL DECISION on the conclusion of the Agreement between the European Union and the Government of the Republic
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 4.1
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, SANCO/D/6/SF/mg/ddg1.d.6(2013) IMPORTATION OF ACTIVE SUBSTANCES
More informationAmsterdam Institute for Advanced labour Studies Coordination of national social security in the EU Jan Cremers Working Paper 10-89 March 2010
AIAS Amsterdam Institute for Advanced labour Studies Coordination of national social security in the EU Jan Cremers Working Paper 10-89 March 2010 AIAS University of Amsterdam Acknowledgement This paper
More informationPossible Revision of the Commission Decision on the minimum set of leased lines. Deadline: 31 March 2004
EUROPEAN COMMISSION Information Society Directorate-General Communication Services: Policy and Regulatory Framework Policy development and regulatory framework Brussels, 3 March 2004 PUBLIC CALL FOR INPUT
More informationA COMPARATIVE TABLE OF THE CURRENT EC AND EU TREATIES AS AMENDED BY THE TREATY OF LISBON
Foreign and Commonwealth Office London A COMPARATIVE TABLE OF THE CURRENT EC AND EU TREATIES AS AMENDED BY THE TREATY OF LISBON 9.25 A COMPARATIVE TABLE OF THE CURRENT EC AND EU TREATIES AS AMENDED BY
More informationNo. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER 5 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008
COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9637/08 SAN 88 DENLEG 52 VETER 7 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER
More informationResponse from REGLEG to the Consultation on the Common Strategic Framework
1 Response from REGLEG to the Consultation on the Common Strategic Framework REGLEG welcomes the early publication of the Commission Staff Working Document Elements for a Common Strategic Framework 2014
More informationSoftware within the medical device regulatory framework in the EU
Software within the medical device regulatory framework in the EU E-HEALTH WEEK (AMSTERDAM, 10 JUNE 2016) Erik Hansson, Deputy Head of Unit, DG GROWTH - Health Technology and Cosmetics, European Commission
More informationA Comparative Case Study on the Relationship between EU Unity and its Effectiveness in Multilateral Negotiations
Is the Sum More than its Parts? A Comparative Case Study on the Relationship between EU Unity and its Effectiveness in Multilateral Negotiations PhD thesis by: Louise van Schaik, July 2010 Promoter/ PhD
More informationTELECOM SOCIETY 2 JULI 2015. Over de moeizame verhouding tussen de privacywet en big data. En wat we daaraan kunnen doen. prof mr.
TELECOM SOCIETY 2 JULI 2015 Over de moeizame verhouding tussen de privacywet en big data. En wat we daaraan kunnen doen prof mr. Gerrit-Jan Zwenne roadmap A. WTF is IoT? What is datafication? And what
More informationOfficial Journal of the European Union. (Acts whose publication is obligatory)
27.12.2006 L 378/1 I (Acts whose publication is obligatory) REGULATION (EC) No 1901/2006 OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 12 December 2006 on medicinal products for paediatric use and amending
More informationLisbon Treaty: impact on EU decision-making
Lisbon Treaty: impact on EU decision-making Daniela Weber-Rey 19 October 2011 Presentation to EIOPA Stakeholder Groups - joint meeting Overview Before and after the Lisbon Treaty Hierarchy of legislation
More informationAuthorisation and Restriction Newsletter
Authorisation and Restriction Newsletter August 2010, N 1 The information contained in this document is intended for guidance only and whilst the information is provided in utmost good faith and has been
More informationMedical Devices: CE Marking Step-by Step
Medical Devices: CE Marking Step-by Step Sylvia Mohr Standards Specialist U.S. Mission to the European Union 1 Introduction CE marking in 8 Steps Overview intended purpose - technical documentation classification
More informationAssuring the Cloud. Hans Bootsma Deloitte Risk Services hbootsma@deloitte.nl +31 (0)6 1098 0182
Assuring the Cloud Hans Bootsma Deloitte Risk Services hbootsma@deloitte.nl +31 (0)6 1098 0182 Need for Assurance in Cloud Computing Demand Fast go to market Support innovation Lower costs Access everywhere
More information8485/15 SC/GDLC/io 1 DGB 1
Council of the European Union Brussels, 5 May 2015 (OR. en) 8485/15 NOTE From: To: Special Committee on Agriculture Council No. prev. doc.: 7524/2/15 REV 2 Subject: AGRI 242 AGRIORG 26 AGRILEG 100 AGRIFIN
More informationCOMMISSION RECOMMENDATION. of XXX
EUROPEAN COMMISSION Brussels, XXX [ ](2013) XXX draft COMMISSION RECOMMENDATION of XXX on the use of common methods to measure and communicate the life cycle environmental performance of products and organisations
More informationEPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical Devices
EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical 03/09/2013 In Vitro Diagnostic medical devices include all tests performed to provide a diagnosis by assessing
More informationCLP regulation & 2015 deadline for mixtures
CLP regulation & 2015 deadline for mixtures CEFIC REACH Information and Experience Exchange Forum Zaventem, 18 December 2013 Maurits-Jan Prinz European Commission DG Enterprise & Industry Table of contents
More informationFRAMEWORK FOR CONSULTATION OF CEIOPS AND OTHER STAKEHOLDERS ON SOLVENCY II
Annex 1 to MARKT/2506/04-EN FRAMEWORK FOR CONSULTATION OF CEIOPS AND OTHER STAKEHOLDERS ON SOLVENCY II Purpose of this document The purpose of this paper is to consult the Insurance Committee on a framework
More informationEmerging Device Topics for Regulatory Consideration.. Janine Jamieson May 2015
Emerging Device Topics for Regulatory Consideration. Janine Jamieson May 2015 Disclaimer These are my personal views and not necessarily those of MHRA as an organisation. 2 European regulation of combination
More informationSAFETY DATA SHEET EVO-STIK PLUMBERS MAIT
Revision Date November 2012 Revision 9 1 / 5 SAFETY DATA SHEET According to Regulation (EC) No 1907/2006 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES GREEN PAPER
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 11.11.2009 COM(2009) 624 final GREEN PAPER on obtaining evidence in criminal matters from one Member State to another and securing its admissibility
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EUROPEAN COMMISSION Brussels, 15.7.2015 COM(2015) 345 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Review of Directive 2010/30/EU of the European Parliament and of the Council
More informationCOMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Proposal for an Interinstitutional Agreement on Better Regulation
EUROPEAN COMMISSION Strasbourg, 19.5.2015 COM(2015) 216 final COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Proposal for an Interinstitutional Agreement on Better Regulation
More informationHandling impact assessments in Council
QC-76-06-353-EN-C EN COUNCIL OF THE EUROPEAN UNION GENERAL SECRETARIAT Handling impact assessments in Council INDICATIVE GUIDANCE FOR WORKING PARTY CHAIRS ISBN 92-824-3284-X,!7IJ2I2-edcieg! kg611572cee_couv.indd
More informationREGULATION (EEC) No 2309/93
REGULATION (EEC) No 2309/93 Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use
More informationTRACTATENBLAD VAN HET KONINKRIJK DER NEDERLANDEN. JAARGANG 2015 Nr. 93
16 (2015) Nr. 1 TRACTATENBLAD VAN HET KONINKRIJK DER NEDERLANDEN JAARGANG 2015 Nr. 93 A. TITEL Verdrag tussen het Koninkrijk der Nederlanden en het Internationaal Strafhof betreffende afspraken voor de
More informationEUROPEAN COMMISSION Employment, Social Affairs and Equal Opportunities DG COMMUNITY PROGRAMME FOR EMPLOYMENT AND SOCIAL SOLIDARITY (PROGRESS)
EUROPEAN COMMISSION Employment, Social Affairs and Equal Opportunities DG Directorate-General General Coordination, Interinstitutional Relations Brussels, 21 December 2006 01/FB D(2006) PROGRESS/003/2006
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health systems and products Medicinal products quality, safety and efficacy Brussels, IMPORTATION OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS
More information2. Europol's cooperation agreements with third countries and international organisations (Art. 31);
Council of the European Union General Secretariat Brussels, 29 September 2015 (OR. en) DS 1532/15 LIMITE MEETING DOCUMENT From: To: Presidency Delegations No. prev. doc.: DS 1497/15, DS 1371/15, DS 1289/1/15
More informationGUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES
Foreword GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES These guidance notes do not aim to be a definite interpretation of National Laws and/or regulations and are for guidance purpose only.
More informationREPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT
EUROPEAN COMMISSION Brussels, 4.2.2015 COM(2015) 43 final REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT 32nd Annual Report from the Commission to the Council and the European Parliament
More information1. Product and Company Identification
Material Safety Data Sheet Oligonucleotide (unmodified and modified) English 1 / 7 1. Product and Company Identification 1.1 Product identifier Chemical Name / Trade Name: Synthetic Nucleic Acid (Oligonucleotide)
More informationHSE: Frequently Asked Questions
HSE: Frequently Asked Questions Q1 - What is GHS? A GHS refers to the United Nations (UN) Globally Harmonised System of Classification and Labelling of Chemicals. The UN published GHS in its publication
More informationStrong support. Remaining concerns
EORTC opinion on the proposal for an EU Regulation on clinical trials on medicinal products for human use and the 7 th of June ENVI report on this proposal It is clear that the Commission and appointed
More informationCouncil of the European Union Brussels, 22 December 2015 (OR. en)
Council of the European Union Brussels, 22 December 2015 (OR. en) 15548/15 POLG 185 NOTE From: To: General Secretariat of the Council Delegations Subject: Provisional agendas for Council meetings, during
More informationISACA Roundtable. Cobit and Grab@Pizza 7 september 2015
1 ISACA Roundtable 7 september 2015 ISACA Roundtable Cobit and Grab@Pizza 7 september 2015 2015 KPN Corporate Market B.V. ISACA, is a registered trademark of the Information Systems Audit and Control Association
More informationActies van Phytofar in het kader van de reductieplannen
Acties van Phytofar in het kader van de reductieplannen Marc Sneyders KVIV Studiedag 06 april 2011 Less use of crop protection products = More sustainability Pesticides This is what most people think about
More informationUEMS 2004 / 47 EN ADOPT ED
EUROPEAN UNION OF MEDICAL SPECIALISTS Kroonlaan 20 Avenue de la Couronne tel: +32-2-649.51.64 B-1050 - BRUSSELS fax: +32-2-640.37.30 www.uems.net uems@skynet.be NEW STATUTES UEMS 2004 / 47 EN ADOPT ED
More informationBehavioral Targeting Legal Developments in Europe and the Netherlands
1 Behavioral Targeting Legal Developments in Europe and the Netherlands Frederik Zuiderveen Borgesius Ph.D researcher, focusing on behavioral targeting and privacy law Institute for Information Law, University
More informationCOMMISSION DECISION. of 19.5.2015. establishing the REFIT Platform
EUROPEAN COMMISSION Strasbourg, 19.5.2015 C(2015) 3261 final COMMISSION DECISION of 19.5.2015 establishing the REFIT Platform EN EN COMMISSION DECISION of 19.5.2015 establishing the REFIT Platform THE
More informationKansen in KP7 NMP. Aansluitend op de HTSM Roadmap Nanotechnologie. 11 juni 2012. Melvin A. Kasanrokijat
Kansen in KP7 NMP Aansluitend op de HTSM Roadmap Nanotechnologie 11 juni 2012 Melvin A. Kasanrokijat Mogelijkheden in KP7 - Cooperation Groot programma met 10 verschillende thema s NMP, ICT, Health, Energy,
More informationSAFETY DATA SHEET BOSTIK AQUAGRIP 536
Revision Date November 2014 1 / 6 SAFETY DATA SHEET BOSTIK AQUAGRIP 536 According to Regulation (EC) No 1907/2006 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1.
More informationRECOMMENDATION 2013/473/EU ON NOTIFIED BODIES AUDITS
RECOMMENDATION 2013/473/EU ON NOTIFIED BODIES AUDITS Questions and Problems in the Field 1 RAin Dr. Angela Graf Bundesverband der Arzneimittel-Hersteller 28. Oktober 2014 RECOMMENDATION 2013/473/EU IN
More information002475/EU XXV. GP. Eingelangt am 18/11/13 COUNCIL OF THE EUROPEAN UNION. Brussels, 18 November 2013 (OR. en)
002475/EU XXV. GP Eingelangt am 18/11/13 COUNCIL OF THE EUROPEAN UNION Brussels, 18 November 2013 (OR. en) 15552/13 Interinstitutional File: 2013/0354 (NLE) AELE 64 EEE 43 CHIMIE 116 AGRILEG 150 LEGISLATIVE
More informationHIPPO STUDY DG Education And Culture Study On The Cooperation Between HEIs And Public And Private Organisations In Europe. Valorisatie 9/26/2013
Valorisatie Hoe goed doen we het in Nederland en doet het HBO het anders dan universiteiten? Peter van der Sijde Todd Davey HIPPO STUDY DG Education And Culture Study On The Cooperation Between HEIs And
More informationAuthorisation and Restriction: Interplay and other Strategic Considerations
Authorisation and Restriction: Interplay and other Strategic Considerations Informa Conference on REACH Montfort, Jean-Philippe Partner +32 (0)2 551 5970 jpmontfort@mayerbrown.com Brussels, 5 March 2012
More informationGMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)
GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) Presented by: Patrick Costello Scientific Administrator, European Medicines Agency An agency of the European
More informationGUIDANCE DOCUMENT No. 10 ON THE APPLICATION OF THE DIRECTIVE ON THE SAFETY OF TOYS MUSIC INSTRUMENTS
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL New Approach Industries, Tourism and CSR International regulatory agreements, toys safety, CSR Last updated: 21/12/2010 GUIDANCE DOCUMENT
More informationDISCUSSION NON-PAPER. How to put ideas for cooperation under TTIP into practice a few examples
1 DISCUSSION NON-PAPER How to put ideas for cooperation under TTIP into practice a few examples Introductory Note: This paper provides descriptions of various processes under REACH and CLP, and is destined
More information002400/EU XXV. GP. Eingelangt am 18/11/13. Brussels, 16 November 2013 COUNCIL OF THE EUROPEAN UNION 16030/1/13 REV 1
002400/EU XXV. GP Eingelangt am 18/11/13 COUNCIL OF THE EUROPEAN UNION Brussels, 16 November 2013 Interinstitutional File: 2013/0255 (APP) 16030/1/13 REV 1 EPPO 20 EUROJUST 114 CATS 77 FIN 735 COPEN 191
More informationPUBLIC COU CIL OF THE EUROPEA U IO. Brussels, 4 July 2011 12373/11. Interinstitutional File: 2011/0023 (COD) LIMITE
eil UE PUBLIC COU CIL OF THE EUROPEA U IO Brussels, 4 July 0 Interinstitutional File: 0/00 (COD) DOCUME T PARTIALLY ACCESSIBLE TO THE PUBLIC (4.0.0) 7/ LIMITE GE VAL 7 AVIATIO 8 DATAPROTECT 7 CODEC 7 OTE
More informationOffshore Wind in Germany
Offshore Wind in Germany Lessons to be learned voor NL ir. Han van Asten, Programma manager TenneT Den Haag, KIVI NIRIA, 'Wind op Zee = Winst voor Nederland', 20 sep 2012 KIVI NIRIA Wind op Zee = Winst
More information12040/1/15 REV 1 LES/ns 1 DG B 3B
Council of the European Union Brussels, 21 September 2015 (OR. en) Interinstitutional File: 2012/0266 (COD) 12040/1/15 REV 1 NOTE From: To: General Secretariat of the Council PHARM 36 SAN 281 MI 567 COMPET
More informationChanges to Medical Device Regulations
Changes to Medical Device Regulations How these will affect distributors? IMSTA Breakfast Briefing, 24 October 2013 Niall MacAleenan Medical Device Lead, IMB. Slide 1 Content Revision of the medical device
More information16525/1/12 REV 1 GS/np 1 DG D 2B
COUNCIL OF THE EUROPEAN UNION Brussels, 3 December 2012 Interinstitutional File: 2012/0011 (COD) 16525/1/12 REV 1 DATAPROTECT 132 JAI 819 DAPIX 145 MI 753 FREMP 141 DRS 131 CODEC 2744 NOTE from: Presidency
More informationRegulatory Strategy for Drug-Device Combinations By John Worroll
THE MEDICAL DEVICE CONSULTING, AUDITING & TRAINING EXPERTS Regulatory Strategy for Drug-Device Combinations By John Worroll Introduction Drug-device combinations have always been a challenge to the regulatory
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex
More informationRULES OF THE TENNESSEE DEPARTMENT OF INTELLECTUAL AND DEVELOPMENTAL DISABILITIES
RULES OF THE TENNESSEE DEPARTMENT OF INTELLECTUAL AND DEVELOPMENTAL DISABILITIES CHAPTER 0465-01-03 ADMINISTRATION OF MEDICATION BY UNLICENSED PERSONNEL TABLE OF CONTENTS 0465-01-03-.01 Purpose 0465-01-03-.06
More informationSection 1: Development of the EU s competence in the field of police and judicial cooperation in criminal matters
CALL FOR EVIDENCE ON THE GOVERNMENT S REVIEW OF THE BALANCE OF COMPETENCES BETWEEN THE UNITED KINGDOM AND THE EUROPEAN UNION Police and Criminal Justice LEGAL ANNEX Section 1: Development of the EU s competence
More informationEvaluation reports from the Commission on Reimbursement of Medicines (CRM) and the Medical Pharmaceutical Committee (MFC) as specific target group
Evaluation reports from the Commission on Reimbursement of Medicines (CRM) and the Medical Pharmaceutical Committee (MFC) as specific target group Philippe Van Wilder RIZIV-INAMI Belgian National Health
More informationCOMMISSION REGULATION (EU) No. of XXX
EUROPEAN COMMISSION Brussels, XXX [...1(2014) XXX draft COMMISSION REGULATION (EU) No of XXX amending Regulation (EC) No 850/2004 of the European Parliament and of the Council on persistent organic pollutants
More informationPharmacy Technician Training Program. Minimum Competencies
1. Pharmacy Practice Pharmacy Technician Training Program Minimum Competencies 1.1 The candidate shall be familiar with the mission of pharmacy and the various permitted pharmacy practice sites. The candidate
More informationEBA/RTS/2016/01. 13 January 2016. Final Report
EBA/RTS/2016/01 13 January 2016 Final Report Final draft regulatory technical standards amending Commission Delegated Regulation (EU) No 1222/2014 on the specification of the methodology for the identification
More informationThe EBA s competence to deliver an opinion is based on the sixth subparagraph of Article 10(1) of Regulation (EU) No 1093/2010 2.
OPINION ON RTS ADDITIONAL COLLATERAL OUTFLOWS EBA/Op/2016/08 03/05/2016 Opinion of the European Banking Authority on the Commission s intention not to endorse the draft Regulatory Technical Standards on
More informationDutch Mortgage Market Pricing On the NMa report. Marco Haan University of Groningen November 18, 2011
Dutch Mortgage Market Pricing On the NMa report Marco Haan University of Groningen November 18, 2011 Introductory remarks My comments are complementary: I do not focus so much on this market as such, more
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a RECOMMENDATION OF THE COUNCIL AND OF THE EUROPEAN PARLIAMENT
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 12.10.2004 COM(2004) 642 final 2004/0239 (COD) Proposal for a RECOMMENDATION OF THE COUNCIL AND OF THE EUROPEAN PARLIAMENT on further European cooperation
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 29 September 2009 13707/09 LIMITE PI 93
COUNCIL OF THE EUROPEAN UNION Brussels, 29 September 2009 13707/09 LIMITE PI 93 WORKING DOCUMENT from: General Secretariat of the Council to: Working Party on Intellectual Property (Patents) No. prev.
More informationBUBBLE JUICE CC AMERICAN DJ
Page : 1/6 HEALT & SAFETY PRODUCT DATA SHEET ( Regulation CE n 1907/2006 changed) BUBBLE JUICE CC Code: 381020 AMERICAN DJ A.D.J. Supply Europe B.V. Junostraat 2 6468 EW Kerkrade - NETHERLANDS Page : 2/6
More informationWorking together for healthier living
Working together for healthier living What is compounding? Compounding is the art and science of preparing custom medications to meet patients unique needs and prescribers exact specifications. The practice
More informationDrafted by ENTSOE. NCs impact DSOs grid ooperation. Approved at EU level. Network Codes. Significant Costs for EU DSOs - billions
Network Codes NCs impact DSOs grid ooperation Significant Costs for EU DSOs - billions Approved at EU level Comitology - Binding legislation for MS Drafted by ENTSOE Network Codes Actors involved DSOs
More informationGeorgios Katsarakis Europäische Kommission
Georgios Katsarakis Europäische Kommission Implementing the Construction Products Regulation (EU) 305/2011 G. Katsarakis European Commission, DG Enterprise and Industry Unit B-1: Sustainable Industrial
More informationSECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING. Enzymatic Drain Cleaner and Maintainer
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier Product name Product No. Enzymatic Drain Cleaner and Maintainer C187 1.2. Relevant identified uses
More informationTERMS OF REFERENCE Electronic Communications Resilience and Response Group (EC RRG)
TERMS OF REFERENCE Electronic Communications Resilience and Response Group (EC RRG) Goal Aims To ensure the availability of Electronic Communications infrastructure for the UK and provide an industry emergency
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 28.11.2008 COM(2008) 798 final COMMUNICATION FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE
More informationEMA Update Clinical Trials
EMA Update Clinical Trials Fergus Sweeney, Head, Compliance and Inspections, European Medicines Agency 16 October 2012 An agency of the European Union Disclaimer The views presented in this presentation/these
More informationLean Maintenance & Asset Management The Best of Both Worlds
Lean Maintenance & Asset Management The Best of Both Worlds Ir. Martin van den Hout CMRP : Asset Management, Maintenance & Reliability Introductie 2 Ir. Martin van den Hout Certified Maintenance & Reliability
More informationCOMMISSION RECOMMENDATION. of XXX. on the right to legal aid for suspects or accused persons in criminal proceedings
EUROPEAN COMMISSION Brussels, XXX C(2013) 8179/2 COMMISSION RECOMMENDATION of XXX on the right to legal aid for suspects or accused persons in criminal proceedings EN EN COMMISSION RECOMMENDATION of XXX
More information16094/14 MM/mj 1 DG E - 1C
Council of the European Union Brussels, 26 November 2014 (OR. en) 16094/14 OUTCOME OF PROCEEDINGS From: On: 25 November 2014 To: CULT 134 AUDIO 69 MI 945 RELEX 980 STATIS 128 Education, Youth, Culture
More informationReporting Changes to your Notified Body
Reporting Changes to your Notified Body Vicky Medley - Head of QMS, Medical Devices September 2015 1) Requirements & Guidance 2) Reporting Changes - What, When, Why & How 3) Some examples 4) Summary &
More informationIP-NBM. Copyright Capgemini 2012. All Rights Reserved
IP-NBM 1 De bescheidenheid van een schaker 2 Maar wat betekent dat nu 3 De drie elementen richting onsterfelijkheid Genomics Artifical Intelligence (nano)robotics 4 De impact van automatisering en robotisering
More informationSamenwerken in/aan een green deal Opties voor CO2 reductie op en rondom het spoor
Samenwerken in/aan een green deal Opties voor CO2 reductie op en rondom het spoor Maart 2013 TRANSPORT minder diesel verbruik = minder CO2 uitstoot Doelstelling voor hybride locomotief Lage snelheid Hoge
More informationResources Based, Manufacturing and Consumer Goods Industries Chemicals Industry
EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry Version March 2015 QUESTIONS
More informationTooth Whitening/Dental Bleaching Products Containing Hydrogen Peroxide in the European Union
Tooth Whitening/Dental Bleaching Products Containing Hydrogen Peroxide in the European Union Proposals to Modify Current Regulations - Submitted to the European Union Scientific Committee on Consumer Products
More informationImporting pharmaceutical products to China
Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval
More information000917/EU XXV. GP. Eingelangt am 06/11/13. Brussels, 6 November 2013 (OR. en) COUNCIL OF THE EUROPEAN UNION 15394/13 ENV 982 MI 927 DELACT 66
000917/EU XXV. GP Eingelangt am 06/11/13 COUNCIL OF THE EUROPEAN UNION Brussels, 6 November 2013 (OR. en) 15394/13 ENV 982 MI 927 DELACT 66 COVER NOTE From: Secretary-General of the European Commission,
More informationEuropean Regulatory Newsletter July - September 2013
European Regulatory Newsletter July - September 2013 Introduction CROMSOURCE is committed to sharing our expertise with our clients and future clients. This reflects the first part of our Advise Agree
More informationEuropean Council Brussels, 2 February 2016 (OR. en)
European Council Brussels, 2 February 2016 (OR. en) EUCO 4/16 NOTE To: Subject: Delegations Draft Decision of the Heads of State or Government, meeting within the European Council, concerning a New Settlement
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL
Ref. Ares(2011)1044649-03/10/2011 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Pharmaceuticals SANCO/D3/RSR/iv(2011)ddg1.d3. 1137738 Update 1 October 2011 HANDLING
More informationUK Indirect Tax Conference 2015 How does the EU do VAT? Aili Nurk 11 November 2015
UK Indirect Tax Conference 2015 How does the EU do VAT? Aili Nurk 11 November 2015 Contents EU Policy lifecycle of a tax change Influencing making it work in practice EU VAT agenda open dossiers Q&A 2
More information